Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Liberati

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
The Netherlands Journal of Medicine|December 22, 2015
A 65-year-old female with poorly controlled type 2 diabetes mellitusA-M Liberati-Čizmek, I Kruljac, M Bakula
Critical Reviews in Oncology/Hematology|April 1, 1996
Chronic myelogenous leukemia: an update on the biological findings and therapeutic approachesA Ferrajoli, M Fizzotti, A M Liberati, et al.
Leukemia Research|December 1, 1993
Molecular diagnosis and monitoring of leukemia and lymphomaE C Borden, J Waalen, A M Liberati, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 1, 1991
Does interferon-beta therapy induce thyroid autoimmune phenomena?M C Pagliacci, G Pelicci, M Schippa, et al.
Journal of Cellular Physiology|November 20, 1997
Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serumL Laricchia-Robbio, S Moscato, A Genua, et al.
Leukemia & Lymphoma|May 7, 1998
Natural and therapy-induced anti-GM-CSF and anti-G-CSF antibodies in human serumR P Revoltella, L Laricchia-Robbio, S Moscato, et al.
Tumori|June 30, 1983
Humoral nonparathyroid hypercalcemia without evidence of bone involvementA M Liberati, F Di Costanzo, C Anasetti, et al.
Leukemia|January 1, 1991
GM-CSF: clinical trials in non-Hodgkin's lymphoma patients with chemotherapy induced leucopeniaA M Liberati, S Cinieri, M Schippa, et al.
Journal of Interferon Research|December 1, 1990
Electrophysiological and neuropsychological functions in patients treated with interferon-betaA M Liberati, S Biagini, G Perticoni, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remissionA M Liberati, M Brugia, B S Edwards, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
The Netherlands Journal of Medicine|December 22, 2015
A 65-year-old female with poorly controlled type 2 diabetes mellitusA-M Liberati-Čizmek, I Kruljac, M Bakula
Critical Reviews in Oncology/Hematology|April 1, 1996
Chronic myelogenous leukemia: an update on the biological findings and therapeutic approachesA Ferrajoli, M Fizzotti, A M Liberati, et al.
Leukemia Research|December 1, 1993
Molecular diagnosis and monitoring of leukemia and lymphomaE C Borden, J Waalen, A M Liberati, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 1, 1991
Does interferon-beta therapy induce thyroid autoimmune phenomena?M C Pagliacci, G Pelicci, M Schippa, et al.
Journal of Cellular Physiology|November 20, 1997
Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serumL Laricchia-Robbio, S Moscato, A Genua, et al.
Leukemia & Lymphoma|May 7, 1998
Natural and therapy-induced anti-GM-CSF and anti-G-CSF antibodies in human serumR P Revoltella, L Laricchia-Robbio, S Moscato, et al.
Tumori|June 30, 1983
Humoral nonparathyroid hypercalcemia without evidence of bone involvementA M Liberati, F Di Costanzo, C Anasetti, et al.
Leukemia|January 1, 1991
GM-CSF: clinical trials in non-Hodgkin's lymphoma patients with chemotherapy induced leucopeniaA M Liberati, S Cinieri, M Schippa, et al.
Journal of Interferon Research|December 1, 1990
Electrophysiological and neuropsychological functions in patients treated with interferon-betaA M Liberati, S Biagini, G Perticoni, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remissionA M Liberati, M Brugia, B S Edwards, et al.
Pageof 7